Artificial Intelligence | Machine Learning Icosavax | Developing Innovative Best-in-Class Vaccines


Consumer, Biotechnology, Health Care, Pharmaceutical, Vaccine Development, Infectious Disease Seattle, WA, United States

Icosavax

Artificial Intelligence | Machine Learning


Icosavax | Developing Innovative Best-in-Class Vaccines

Icosavax

Biotechnology, Health Care, Pharmaceutical, Vaccine Development, Infectious Disease


Seattle, WA, United States

Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally-designed virus-like particle technology, exclusively licensed for a variety of infectious disease indications from the Institute for Protein Design at the University of Washington. Icosavax is located in Seattle.

By utilizing computationally designed proteins that self-assemble into virus-like particles (VLPs), we are able to readily manufacture VLPs displaying complex antigens to target significant unmet medical needs.

 
 

   Total Funding: $161 M

   Funding Stage: Series B

   Business Stage: Scaling Up

   Market: B2C

   Company Size: 26 to 50

   Founded: 2017

 
 

Date

Round

$ Raised

Investors

04/07/2021

Series B

$100M

Viking Global Investors, Sanofi Ventures, RA Capital Management, Qiming Venture Partners USA, Perceptive Advisors, Omega Healthcare Investors, NanoDimension, Janus Henderson Investors, Cormorant Asset Management, Adams Street Partners

Date : 04/07/2021

Round: Series B

$ Raised: $100M

Investors: Viking Global Investors, Sanofi Ventures, RA Capital Management, Qiming Venture Partners USA, Perceptive Advisors, Omega Healthcare Investors, NanoDimension, Janus Henderson Investors, Cormorant Asset Management, Adams Street Partners

 

For AI/ML Startup Founders

Get introduced to VC/PE/CVC investors

For Investors at VC/PE firms

Get introduced to AI/ML Startup founders or founders at Icosavax

 
 
 
Adam Simpson


Adam Simpson
Chief Executive Officer & Co-Founder

Cassia Cearley


Cassia Cearley
Chief Business Officer

Douglas Holtzman


Douglas Holtzman
CSO

Niranjan Kanesa-thasan MD MTMH


Niranjan Kanesa-thasan MD MTMH
Chief Medical Officer

 
 

Icosavax is growing. Want to work at Icosavax? Icosavax is hiring. Join team at Icosavax

 

View All

Director, Preclinical Development

Seattle, Washington

VP of Legal Affairs

Seattle, Washington

Manager, Quality Assurance

Seattle, Washington

Senior Research Associate, CMC

Seattle, Washington

Senior Program Manager

Seattle, Washington

 
 
appengine.ai

World's Most Promising AI/ML Startups